Funding for this research was provided by:
HIV, Hepatitis and Related Conditions Programs (.)
AHRQ (K12 HS019461)
Received: 17 August 2018
Accepted: 25 March 2019
First Online: 8 April 2019
Ethics approval and consent to participate
: The Pittsburgh VA IRB determined that the initiative was exempt under a provision applying to quality improvement. This study was approved by the HIV, Hepatitis and Related Conditions Programs in the Office of Specialty Care Services as a quality improvement project as a part of the program evaluation for the Hepatitis C Innovation Team Collaborative.
: Figure InternalRef removed is adapted from a previously-published image from Dr. Waltz et al’s paper and is used with his permission.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.